eMedicine from WebMD
eMedicine Home
Commercial support provided by Amylin Pharmaceuticals, Inc. and Eli Lilly and Company.
<< BYETTA InfoSite Home

BYETTA® is easy to use and easy to add to current therapies



BYETTA is convenient and easy to use, and it's simple to start.

  Easy, fixed dosing.

  No additional glucose monitoring.

  More convenient storage.*


dosing
* Prior to first use, BYETTA should be refrigerated at 36ºF to 46ºF (2ºC to 8ºC). After the BYETTA Pen is first used, it can be stored at a temperature not to exceed 77ºF (25ºC). Do not freeze.



<< BYETTA InfoSite Home


BYETTA is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin, a sulfonylurea, a thiazolidinedione, a combination of metformin and a sulfonylurea, or a combination of metformin and a thiazolidinedione, but have not achieved adequate glycemic control.

For Important Safety Information, please click here and for complete safety profile and other important prescribing considerations, see the full Prescribing Information.

References

02-07-5549-A ©2007 Amylin Pharmaceuticals, Inc. and Eli Lilly and Company.
The BYETTA mark and BYETTA design mark are trademarks of Amylin Pharmaceuticals, Inc.